Latest Photocure ASA (PHCUF) Headlines Acne V
Post# of 3
Posted On: 03/11/2014 12:05:04 AM
Latest Photocure ASA (PHCUF) Headlines
Acne Vulgaris Global Clinical Trials Review, H2, 2013 is Essential Reading for Pharma Sector and Dermatologists Alike
M2 - Tue Oct 08, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bsggsl/acne_vulgaris) has announced the addition of the "Acne Vulgaris Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acne Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: - Actavis Mid Atlantic LLC - Allergan, Inc. - Apex Healthcare Limited - Bayer AG - Clinical Trial Overview of GlaxoSmithKline plc - Clinical Trial Overview of Photocure ASA - Dow Pharmaceutical Sciences Inc. - Dr. Reddy's Laboratories Limited - Galderma S.A. - GlaxoSmithKline plc - Glenmark Pharmaceuticals Ltd. - Intendis GmbH - Johnson & Johnson - Maruho Co., Ltd. - Novan, Inc. - Perrigo Company - Pfizer Inc. - Photocure ASA - Stiefel Laboratories, Inc. - Taro Pharmaceutical Industries Ltd. - Valeant Pharmaceuticals International, Inc. - Verisfield (UK) Ltd For more information visit http://www.researchandmarkets.com/research/bs...e_vulgaris About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
'Acne Vulgaris - Pipeline Review, H2 2013' Contains Discovery and Pre-Clinical Stage Products
M2 - Tue Sep 03, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mddqlt/acne_vulgaris) has announced the addition of the "Acne Vulgaris - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. Scope - A snapshot of the global therapeutic scenario for Acne Vulgaris. - A review of the Acne Vulgaris products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Acne Vulgaris pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Normal 0 false false false MicrosoftInternetExplorer4 Advancell AndroScience Corporation AntiCancer, Inc. Ausio Pharmaceuticals, LLC Boehringer Ingelheim GmbH Braintree Laboratories, Inc. Ensoltek Co., Ltd. Foamix Ltd. Galderma S.A. Hygeia Therapeutics, Inc. Lee's Pharmaceutical Holdings Limited Maruho Co.,Ltd. Medicis Pharmaceutical Corporation NanoBio Corporation Phosphagenics Limited Photocure ASA Quest PharmaTech Inc. Toyama Chemical Co. Ltd Valeant Pharmaceuticals International XBiotech USA, Inc. XOMA Ltd. For more information visit http://www.researchandmarkets.com/research/md...ne_vulgari About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cervical Cancer Global Clinical Trials Review, H2, 2012 Features Players such as Pfizer Inc. and Bristol-Myers Squibb Company
M2 - Wed Jan 09, 7:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/qfqxgc/cervical_cancer) has announced the addition of GlobalData's new report "Cervical Cancer Global Clinical Trials Review, H2, 2012" to their offering. The clinical trial report, Cervical Cancer Global Clinical Trials Review, H2, 2012" provides data on the Cervical Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope - Data o
Acne Vulgaris Global Clinical Trials Review, H2, 2013 is Essential Reading for Pharma Sector and Dermatologists Alike
M2 - Tue Oct 08, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bsggsl/acne_vulgaris) has announced the addition of the "Acne Vulgaris Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acne Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: - Actavis Mid Atlantic LLC - Allergan, Inc. - Apex Healthcare Limited - Bayer AG - Clinical Trial Overview of GlaxoSmithKline plc - Clinical Trial Overview of Photocure ASA - Dow Pharmaceutical Sciences Inc. - Dr. Reddy's Laboratories Limited - Galderma S.A. - GlaxoSmithKline plc - Glenmark Pharmaceuticals Ltd. - Intendis GmbH - Johnson & Johnson - Maruho Co., Ltd. - Novan, Inc. - Perrigo Company - Pfizer Inc. - Photocure ASA - Stiefel Laboratories, Inc. - Taro Pharmaceutical Industries Ltd. - Valeant Pharmaceuticals International, Inc. - Verisfield (UK) Ltd For more information visit http://www.researchandmarkets.com/research/bs...e_vulgaris About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
'Acne Vulgaris - Pipeline Review, H2 2013' Contains Discovery and Pre-Clinical Stage Products
M2 - Tue Sep 03, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mddqlt/acne_vulgaris) has announced the addition of the "Acne Vulgaris - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. Scope - A snapshot of the global therapeutic scenario for Acne Vulgaris. - A review of the Acne Vulgaris products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Acne Vulgaris pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Normal 0 false false false MicrosoftInternetExplorer4 Advancell AndroScience Corporation AntiCancer, Inc. Ausio Pharmaceuticals, LLC Boehringer Ingelheim GmbH Braintree Laboratories, Inc. Ensoltek Co., Ltd. Foamix Ltd. Galderma S.A. Hygeia Therapeutics, Inc. Lee's Pharmaceutical Holdings Limited Maruho Co.,Ltd. Medicis Pharmaceutical Corporation NanoBio Corporation Phosphagenics Limited Photocure ASA Quest PharmaTech Inc. Toyama Chemical Co. Ltd Valeant Pharmaceuticals International XBiotech USA, Inc. XOMA Ltd. For more information visit http://www.researchandmarkets.com/research/md...ne_vulgari About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cervical Cancer Global Clinical Trials Review, H2, 2012 Features Players such as Pfizer Inc. and Bristol-Myers Squibb Company
M2 - Wed Jan 09, 7:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/qfqxgc/cervical_cancer) has announced the addition of GlobalData's new report "Cervical Cancer Global Clinical Trials Review, H2, 2012" to their offering. The clinical trial report, Cervical Cancer Global Clinical Trials Review, H2, 2012" provides data on the Cervical Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cervical Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope - Data o
(0)
(0)Photocure Asa (PHCUF) Stock Research Links
Scroll down for more posts ▼